Aug 26, 2026, 6:00 AM EDT · 5 weeks ago EUDA Health Subsidiary Melana International Wins SME100 Awards 2026 Singapore
2026-07-30T11:51:23.000Z · 2 months ago EUDA Health enters collaboration for integrated iPSC cell therapy program
Jul 30, 2026, 6:00 AM EDT · 2 months ago EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products
Jul 28, 2026, 6:00 AM EDT · 2 months ago EUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell Therapies
2026-07-14T14:20:10.000Z · 2 months ago EUDA Health Holdings Ltd trading halted, volatility trading pause
Jun 1, 2026, 6:05 AM EDT · 4 months ago EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask
Jun 1, 2026, 6:00 AM EDT · 4 months ago EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency
2026-05-07T04:10:48.000Z · 4 months ago EUDA Health Holdings Ltd trading halted, volatility trading pause
2026-04-29T16:31:53.000Z · 5 months ago EUDA Health Holdings Ltd trading halted, volatility trading pause
Apr 28, 2026, 6:00 AM EDT · 5 months ago EUDA Highlights Shenzhen Inno's Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy Development
2026-04-27T14:38:56.000Z · 5 months ago EUDA Health Holdings Ltd trading halted, volatility trading pause
2026-04-27T10:17:45.000Z · 5 months ago EUDA Health receives listing noncompliance notice from Nasdaq
2026-04-23T13:37:27.000Z · 5 months ago EUDA Health Holdings Ltd trading halted, volatility trading pause
2026-03-09T14:00:42.000Z · 6 months ago EUDA Health price target lowered to $2.75 from $6 at Greenridge
2026-03-04T14:16:22.000Z · 7 months ago EUDA Health announces repurchase, cancellation of Streeterville warrant
Mar 4, 2026, 9:10 AM EST · 7 months ago EUDA Health Holdings Limited Announces Repurchase and Cancellation of Streeterville Warrant
2026-01-15T14:05:15.000Z · 8 months ago EUDA Health announces second amendment to Streeterville warrant agreement
Jan 13, 2026, 7:49 AM EST · 8 months ago EUDA Enters into Convertible Loan Agreement with Shenzhen Inno, Further Expanding Stem Cell Therapy Platform
Jan 7, 2026, 6:00 AM EST · 8 months ago EUDA Health Holdings Limited Announces Amendment to Streeterville Warrant Agreement
Dec 30, 2025, 7:00 AM EST · 9 months ago EUDA Launches Nationwide Stem Cell Extraction, Cryostorage and Clinical Delivery Platform in China with Shenzhen Inno Immune and Wuhan Kaien Hospital
Dec 23, 2025, 7:00 AM EST · 9 months ago EUDA Accelerates Longevity Strategy with Launch of Comprehensive Stem Cell Therapy Platform and First Clinic in Shenzhen
Dec 22, 2025, 7:00 AM EST · 9 months ago EUDA Integrates QB Utility Token to Create a Digital Health and Rewards Platform Across Its Healthcare Ecosystem
Dec 5, 2025, 9:30 AM EST · 10 months ago EUDA Health Holdings Limited Announces Execution of Securities Purchase Agreement
Dec 16, 2024, 5:00 PM EST · 1 year ago EUDA Holdings and Guangdong Cell Biotech Explore Potential Strategic Partnership to Advance Biotechnology Innovation
Aug 20, 2024, 7:00 AM EDT · 2 years ago Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now CIA CVKD ELUT GDTC GOSS GOVX IMRN
May 8, 2024, 8:44 AM EDT · 2 years ago EUDA Health Holdings Limited Completes Acquisition of CK Health Plus Sdn Bhd, Expanding into Direct Selling Holistic Wellness Products in Southeast Asia
May 6, 2024, 5:00 PM EDT · 2 years ago EUDA Health Expands into Direct Selling Holistic Wellness Products with Acquisition of CK Health
Jan 16, 2024, 6:15 PM EST · 2 years ago EUDA Health Holdings Limited Has Regained Compliance with Nasdaq Capital Market's Continued Listing Requirements After receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency
Jan 16, 2024, 5:29 PM EST · 2 years ago EUDA Health Holdings Limited Has Received Nasdaq Notification Regarding Minimum Market Value Deficiency
Oct 5, 2023, 9:00 AM EDT · 2 years ago EUDA Health Holdings Limited Enters into Letter of Intent for Proposed Merger with TheoremRx Inc.
Sep 22, 2023, 8:00 AM EDT · 3 years ago EUDA Health Holdings Limited Has Regained Compliance with Nasdaq Capital Market's Continued Listing Requirements
Aug 14, 2023, 8:15 AM EDT · 3 years ago EUDA Health Holdings Limited Receives Nasdaq Notification Regarding Non-Compliance with Minimum Bid Price Requirement
Aug 4, 2023, 8:30 AM EDT · 3 years ago EUDA Health Holdings Limited Receives Nasdaq Notification Regarding Minimum Market Value Deficiency
May 19, 2023, 4:05 PM EDT · 3 years ago EUDA Health Holdings Limited Announces Receipt of Nasdaq Listing Delinquency Letter